LoginGet started
Picture of Bora Pharmaceuticals Co logo

6472 — Bora Pharmaceuticals Co Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Bora Pharmaceuticals Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3255951,0241,8404,064
Depreciation
Amortisation
Non-Cash Items28.5-33770.61971,269
Unusual Items
Other Non-Cash Items
Changes in Working Capital-242-221-68.1-352-1,325
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities2321781,2372,0104,614
Capital Expenditures-699-152-364-193-1,389
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-129-1,386138-4,088-1,069
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-827-1,538-226-4,281-2,458
Financing Cash Flow Items-11.7-19-54.3472-85.7
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5511,578-7414,595-2,440
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-44.92172412,371-228